Announced
Completed
AstraZeneca, CR Capital Magament and Panlin capital led a $50m Series B round in NuProbe.
Synopsis
AstraZeneca, CR Capital Magament and Panlin capital led a $50m Series B round in NuProbe, a biotechnology company, with participation from Gaorong Capital, Deguan Capital, Pappas Capital, BioTrack Capital, Sequoia, Yonghua Capital and Tuobang Capital.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite